View Older Stories View More Recent Stories
-
BMO Financial Group Receives 2017 Thomson Reuters/S-Network ESG Best Practices Award
-
Norbord (OSB) 3.55M Shares from Brookfield Offered at $42.35/Share
-
AK Steel Announces Pricing of $280,000,000 of Senior Notes due 2025
-
Norbord Inc. Announces Secondary Bought Deal Offering of Its Common Shares by Brookfield
-
Resolute Energy Corporation Announces Appointment of Tod Benton and Janet Pasque to Board of Directors
-
National Storage Affiliates Trust Reports Second Quarter 2017 Results; Net Income Increases $9.6 Million; Core FFO Per Share Increases 10.7%; Same Store NOI Increases 8.4%; Acquired 10 Self Storage Pr
-
Last Week's Best Performing Shorts - S3
-
Spark Therapeutics (ONCE) PT Raised to $89 at BMO Capital
-
Bright Horizons (BFAM) PT Raised to $85 at BMO Capital on 2Q Report; 'Organic Growth Improved'
-
FireEye, Inc (FEYE) PT Raised to $17 at BMO Capital on 2Q Report; 'Position with Customers Continues to Improve'
-
DexCom (DXCM) PT Lowered to $90 at BMO Capital Following 2Q on 'Near-Term Medicare Reimbursement Disruption'
-
StreetInsider.com Premium Hot Research Recap 08/02
-
Mosaic (MOS) PT Lowered to $25 at BMO Capital on 2Q Report; 'Phosphate Margin Squeeze... On Weak Fundamentals'
-
AK Steel Announces Offering of $280,000,000 of Senior Notes and Cash Tender Offer for its 8.375% Senior Notes due 2022
-
BMO Capital Upgrades Pfizer (PFE) to Outperform
-
Apple (AAPL) PT Raised to $180 at BMO Capital
-
Kosmos Energy Announces Intention to Pursue Secondary Listing on the London Stock Exchange
-
Sienna Biopharmaceuticals Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Intercept Pharmaceuticals (ICPT) PT Raised to $221 at BMO Capital on 2Q Report; 'Solid 2Q17 Earnings + Two Positive Phase 2 Readouts... Buy on Weakness'
-
Fiserv (FISV) PT Raised to $133 at BMO Capital Ahead of 2Q Report Today AMC; 'Slight EPS Beat Expected on Margin Expansion with Scale'
-
AGCO Corporation (AGCO) PT Raised to $75 at BMO Capital on 2Q Report; 'Operating at a High Level... Outperformance Continues from European Segment'
-
Gentherm Incorporated (THRM) PT Lowered to $42 at BMO Capital on 2Q Miss; 'Negatively Affected by Sales Mix & Lower Auto Production'
-
Pandora (P) PT Lowered to $11 at BMO Capital on 2Q Report; 'Listener Hour/Active User Growth Rates Lack Visibility'
-
BMO Capital Starts Criteo S.A. (CRTO) at Outperform
-
Pandora (P) PT Lowered to $11 at BMO Capital
-
Osisko Completes Acquisition of Orion Royalty Portfolio
-
TMI Trust Company Accepts The Trustee And Custody Services Portfolio From BMO Global Asset Management's Family Office Business
-
Form 13F-NT BMO CAPITAL MARKETS CORP For: Jun 30
-
Coca-Cola (KO) PT Raised to $47 at BMO Capital on 2Q Report; 'Encouraging Progress, Despite Rich Valuation'
-
Flowserve Corp. (FLS) PT Raised to $48 at BMO Capital; Stabilizing Pricing & End-Market Activity Continues to Support Recommendation of Shares
-
Pre-Open Stock Movers 07/31: (DVAX) (CHTR) (DAN) Higher; (HTZ) (CLVS) (ICPT) Lower (more...)
-
Industry Leaders Pack Speaker Slate for A&D Strategies Conference and Workshop
-
Mattel Inc. (MAT) PT Lowered to $25 at BMO Capital on 2Q Miss; 'Maintains Guidance... Buying Opportunity for Investors with Longer-Term Horizon'
-
Regeneron (REGN): Sanofi Weakness Could Pressure Shares - BMO
-
Platinum Group Metals Ltd. Operational and Strategic Process Update
-
Contura Energy Inc. (CTRA) Announces 6M Share IPO; Anticipated Price Between $23-$27
-
Contura Announces Launch of Initial Public Offering
-
BMO Capital Upgrades Covanta (CVA) to Outperform
-
BMO Capital Upgrades Wells Fargo (WFC) to Market Perform
-
BMO Capital Downgrades Citi (C) to Market Perform
-
Dollar falls on ECB bets, month-end moves
-
Alexion Pharmaceuticals (ALXN) PT Raised to $168 at BMO Capital on 2Q Beat; 'Upside in Soliris Sales, Upward Revision to Sales Guidance'
-
Celgene (CELG) PT Raised to $160 at BMO Capital; 'Revlimid Gaining Traction in Europe... Growth Should Accelerate Through 2017'
-
ADP (ADP) PT Raised to $105 at BMO Capital on 4Q Report; 'Ackman Bounce Negates Weak Trends'
-
Flowserve Corp. (FLS) PT Lowered to $47 at BMO Capital; '2Q17 Very Poor... Sales, Margin, Earnings Miss, Guidance Lowered'
-
UPDATE: BMO Capital Reiterates Outperform Rating & $1200 PT on Amazon.com (AMZN) 2Q Report; 'Very Strong Revenue Growth, Muted Margins'
-
Starbucks (SBUX) PT Lowered to $64 at BMO Capital on 3Q Report; 'Softer Global Comps & Weaker Operating Margins'
-
Bristol-Myers Squibb (BMY): IO Uncertainty Drives PT Decrease - BMO
-
Tetraphase Pharma (TTPH) Prices 10M Shares at $6.50/Sh
-
Tetraphase Announces Pricing of Public Offering of Common Stock

